Global Osteoporosis Clinical Trials Review 2023: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
January 31, 2024 06:57 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis - Global Clinical Trials Review, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Heart Failure Therapeutics Market is expected to generate a revenue of USD 15 billion by 2029 Globally at a 3.8% CAGR
September 15, 2022 06:08 ET
|
Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
Osteoporosis Therapeutics Market to Top US$ 14 Bn Valuation by 2026: Fact.MR Analysis
May 15, 2022 20:00 ET
|
FACT.MR
United States, Rockville MD, May 15, 2022 (GLOBE NEWSWIRE) -- Demand for osteoporosis therapeutics is anticipated to increase at a CAGR of 2.9% from 2022 to 2026, as per this new analysis by...
Osteoporosis Therapeutics in Asia-Pacific (APAC) Markets to 2022: Industry Size, Shares, Trends, Opportunities, Survey and Forecast: ResearchMoz
August 22, 2016 06:30 ET
|
Researchmoz Global Pvt Ltd
Albany, NY, Aug. 22, 2016 (GLOBE NEWSWIRE) -- Osteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a...